Small Business FDA User Fee Adjustment Act of 2021
Official title: To amend the Federal Food, Drug, and Cosmetic Act to waive or reduce the amount of over-the-counter monograph fees applicable to small businesses, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
Small Business FDA User Fee Adjustment Act of 2021
This bill reduces and waives certain fees related to marketing certain over-the-counter (OTC) drugs for businesses with fewer than 500 employees, including employees of affiliates.
Starting in FY2022, the Food and Drug Administration (FDA) must waive the fee for the first OTC monograph order request from such a business. (Generally, an OTC monograph order request is a request for the FDA to evaluate whether a nonprescription drug meets certain standards.)
The fee for each subsequent OTC monograph order request for such a business shall be 25% of the amount otherwise owed.
For such a business, the FDA must also reduce the annual OTC monograph drug facility fee to 25% of the amount otherwise owed. (Generally, such a facility is engaged in the manufacturing or processing of an OTC monograph drug.)
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 4405: Small Business FDA User Fee Adjustment Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-4405/
"H.R. 4405: Small Business FDA User Fee Adjustment Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-4405/.
H.R. 4405, 117th Cong. (2026), https://openamerica.io/bill/117-HR-4405/.
[H.R. 4405: Small Business FDA User Fee Adjustment Act of 2021](https://openamerica.io/bill/117-HR-4405/)